TELA Bio
TELA
47 hedge funds and large institutions have $81.6M invested in TELA Bio in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 15 closing their positions.
227,500% more call options, than puts
Call options by funds: $2.28M | Put options by funds: $1K
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
79% more capital invested
Capital invested by funds: $45.6M → $81.6M (+$36.1M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 49 → 47 (-2)
4.27% less ownership
Funds ownership: 72.89% → 68.63% (-4.3%)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$5.46M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.96M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$4.05M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.5M |
| 5 |
RA
Royce & Associates
New York
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$5.47M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$1.89M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$501K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$290K |
| 5 |
Millennium Management
New York
|
-$277K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TI
51
Trexquant Investment
Stamford,
Connecticut
| – | -$130K | -51,472 | Closed |
|
52
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$66.8K | -26,401 | Closed |
|
53
Wells Fargo
San Francisco,
California
| – | -$42.3K | -16,718 | Closed |
|
54
Squarepoint
New York
| – | -$34K | -13,422 | Closed |
|
|
XT
55
XTX Topco
George Town,
Cayman Islands
| – | -$31.7K | -12,549 | Closed |
|
|
SSA
56
Schonfeld Strategic Advisors
New York
| – | -$30.9K | -12,200 | Closed |
|
57
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$25.6K | -10,113 | Closed |
|
|
CFM
58
Catalyst Funds Management
Sydney NSW,
Australia
| – | -$10.1K | -4,000 | Closed |
|
59
Jones Financial Companies
Des Peres,
Missouri
| – | -$4.96K | -1,888 | Closed |
|
|
BL
60
BFSG LLC
Irvine,
California
| – | -$1.33K | -525 | Closed |
|
|
AAP
61
Arax Advisory Partners
Denver,
Colorado
| – | -$152 | -60 | Closed |
|
TELA Hedge Fund Activity: Q4 2024 in Review
47 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q4 2024, worth a combined $81.6M — up 79% from $45.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of TELA and 13 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 21 added.
The largest buyer was Silverarc Capital Management, adding an estimated $5.46M. The largest seller was OrbiMed, exiting entirely with an estimated $5.47M sold.
- 47 institutional investors held TELA Bio (TELA) as of Q4 2024, down from 49 in Q3 2024.
- Funds reported $81.6M of TELA Bio stock for Q4 2024, up 79% quarter-over-quarter.
- 13 funds opened new TELA Bio positions in Q4 2024 and 15 closed out, a net change of -2 holders.
- The largest TELA Bio buyer in Q4 2024 was Silverarc Capital Management, an estimated $5.46M added.
- The largest TELA Bio seller in Q4 2024 was OrbiMed, an estimated $5.47M sold.
Based on aggregated 13F filings for Q4 2024.